REVERT - taRgeted thErapy for adVanced colorEctal canceR paTients

Interesting interview of Prof. Mario Roselli about the opportunity of the Revert project for the colorectal cancer patients

Prof. Mario Roselli, Director of the Medical Oncology Unit and Full Professor at the University Hospital Tor Vergata was interviewed…

09/12/2023

From April 24 to 27, 2023, UCAM Universidad Católica de Murcia held in its facilities the VII UCAM International Staff…

07/03/2023

The REVERT (taRgeted thErapy for adVanced colorEctal canceR paTients) project, financedby the European Horizon 2020 Programme and led by the…

06/22/2023

The Regional Institute of Oncology – Iasi, Romania, partner of the REVERT project, is looking for: a Colorectal surgeon a…

06/21/2023

PROJECT DESCRIPTION The Regional Institute of Oncology – Iasi, Romania, is looking for a Colorectal surgeon within the REVERT team.…

06/20/2023

PROJECT DESCRIPTION The Regional Institute of Oncology – Iasi, Romania, is looking for a PhD Researcher within the REVERT team.…

06/20/2023

REVERT Project promoted on FAIR: “GET CLOSER TO EUROPE IN THE REGION OF MURCIA” As every year, the “Europe Day”…

06/08/2023

In February 09-10 2023 the REVERT partners met in Cartagena and Murcia todiscuss about the activities carried out since the beginning of the…

02/20/2023

In November 28-29 2022 the REVERT partners met in Rome in the San Raffaele Research Center headquarters, leader of the…

12/21/2022

Revert was promoted in the latest issue of the HiPEACH network newsletter (European Network of Excellence on High Performance and…

10/19/2022

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 848098”.